Literature DB >> 18566383

B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones.

Rie Takagi1, Takehiro Higashi, Kumiko Hashimoto, Kazuhisa Nakano, Yosuke Mizuno, Yasushi Okazaki, Sho Matsushita.   

Abstract

Th 17 cells represent a novel subset of CD4+ T cells that have a protective effect against extracellular microbes, while they are also responsible for autoimmune disorders in mice. However, the protein expression profile of Th17 cells remains to be clarified. In this study, we report an effective method to establish human allo-reactive Th17 cell clones and demonstrate that human Th17, but not Th1 or Th2, cells express B cell chemoattractant CXCL13, by using DNA chips, RT-PCR, and ELISA. Such a pattern was also the case in Candida albicans-specific Th17 clones and synovial fluid specimens obtained from patients with rheumatoid arthritis. The biological implication of this finding is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566383     DOI: 10.4049/jimmunol.181.1.186

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  MCAM-expressing CD4(+) T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases.

Authors:  Pradeep K Dagur; Angélique Biancotto; Lai Wei; H Nida Sen; Michael Yao; Warren Strober; Robert B Nussenblatt; J Philip McCoy
Journal:  J Autoimmun       Date:  2011-09-29       Impact factor: 7.094

Review 2.  Precarious balance: Th17 cells in host defense.

Authors:  Ariana Peck; Elizabeth D Mellins
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

3.  Complex association patterns for inflammatory mediators in induced sputum from subjects with asthma.

Authors:  A T Hastie; C Steele; C W Dunaway; W C Moore; B M Rector; E Ampleford; H Li; L C Denlinger; N Jarjour; D A Meyers; E R Bleecker
Journal:  Clin Exp Allergy       Date:  2018-04-15       Impact factor: 5.018

4.  Transconjunctival immunotherapy using cholera toxin B to treat experimental allergic conjunctivitis in a mouse model.

Authors:  Aki Oikawa; Jun Shoji; Noriko Inada; Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2011-08-09       Impact factor: 2.447

Review 5.  To B or not to B the conductor of rheumatoid arthritis orchestra.

Authors:  Rita A Moura; Luis Graca; João E Fonseca
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 6.  Cytokines and Chemokines in Mycobacterium tuberculosis Infection.

Authors:  Racquel Domingo-Gonzalez; Oliver Prince; Andrea Cooper; Shabaana A Khader
Journal:  Microbiol Spectr       Date:  2016-10

Review 7.  Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma.

Authors:  Elena Vendrame; Otoniel Martínez-Maza
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

8.  Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.

Authors:  Shehnaz K Hussain; Weiming Zhu; Shen-Chih Chang; Elizabeth Crabb Breen; Elena Vendrame; Larry Magpantay; Dan Widney; Daniel Conn; Mary Sehl; Lisa P Jacobson; Jay H Bream; Steven Wolinsky; Charles R Rinaldo; Richard F Ambinder; Roger Detels; Zuo-Feng Zhang; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-18       Impact factor: 4.254

9.  Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge.

Authors:  Hiromasa Hamada; Maria de la Luz Garcia-Hernandez; Joyce B Reome; Sara K Misra; Tara M Strutt; Kai K McKinstry; Andrea M Cooper; Susan L Swain; Richard W Dutton
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

10.  Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels.

Authors:  Zeina Jaffar; Maria E Ferrini; Lou A Herritt; Kevan Roberts
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.